A
Aerwave Medical
Health Tech & Medtech · New York City, United States · Founded 2020
Developing a unique alternative to traditional medications used to treat COPD and asthma MoreLess
AerWave Medical is at the forefront of transforming the treatment of pulmonary diseases such as asthma, Chronic Obstructive Pulmonary Disease (COPD), and other advanced lung conditions through an innovative interventional approach. The company targets patients suffering from these chronic respiratory conditions, providing them with alternatives to traditional medication-based treatments. Operating within the healthcare and medical technology market, AerWave Medical leverages cutting-edge research and development to create minimally invasive procedures that aim to improve patient outcomes and quality of life. The business model revolves around developing and commercializing these medical interventions, generating revenue through the sale of proprietary medical devices and therapies to healthcare providers and institutions. By focusing on unmet medical needs and harnessing a world-class management team, AerWave Medical positions itself as a leader in the pulmonary care sector.
Keywords: pulmonary disease, asthma, COPD, interventional therapy, medical technology, healthcare innovation, minimally invasive, chronic respiratory conditions, patient outcomes, proprietary devices.
Talent graph
Aerwave Medical's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Aerwave Medical has talent and traffic
Market sentiment
What the market is saying about Aerwave Medical
An AI-synthesized read of the highest-engagement posts about Aerwave Medical on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Aerwave Medical on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.